1: Thiele H, Møller JE, Henriques JPS, Bogerd M, Seyfarth M, Burkhoff D, Ostadal
P, Rokyta R, Belohlavek J, Massberg S, Flather M, Hochadel M, Schneider S, Desch
S, Freund A, Eiskjær H, Mangner N, Pöss J, Polzin A, Schulze PC, Skurk C, Zeymer
U, Hassager C; MCS Collaborator Scientific Group. Temporary mechanical
circulatory support in infarct-related cardiogenic shock: an individual patient
data meta-analysis of randomised trials with 6-month follow-up. Lancet. 2024 Sep
14;404(10457):1019-1028. doi: 10.1016/S0140-6736(24)01448-X. Epub 2024 Sep 2.
Erratum in: Lancet. 2024 Sep 28;404(10459):1198. doi:
10.1016/S0140-6736(24)02088-9. PMID: 39236726.

2: Obradovic D, Loncar G, Zeymer U, Pöss J, Feistritzer HJ, Freund A, Jobs A,
Fuernau G, Desch S, Ceglarek U, Isermann B, von Haehling S, Anker SD, Büttner P,
Thiele H. Impact of anaemia and iron deficiency on outcomes in cardiogenic shock
complicating acute myocardial infarction. Eur J Heart Fail. 2024
Feb;26(2):448-457. doi: 10.1002/ejhf.3099. Epub 2024 Jan 1. PMID: 38084483.

3: Thiele H, Desch S, Zeymer U. Extracorporeal Life Support in Infarct-Related
Cardiogenic Shock. Reply. N Engl J Med. 2024 Jan 11;390(2):190-191. doi:
10.1056/NEJMc2312854. PMID: 38197835.

4: Lehrke M, Fuernau G, Jung C, Kahles F, Moellmann J, Eitel I, Thelemann N,
Desch S, Werdan K, Zeymer U, Adams V, Marx N, Thiele H. GLP-1 in patients with
myocardial infarction complicated by cardiogenic shock-an IABP-SHOCK II-
substudy. Clin Res Cardiol. 2024 Aug;113(8):1211-1218. doi:
10.1007/s00392-023-02366-2. Epub 2024 Jan 3. PMID: 38170249.

5: Desch S, Zeymer U, Akin I, Behnes M, Duerschmied D, Rassaf T, Mahabadi AA,
Lehmann R, Eitel I, Graf T, Seidler T, Schuster A, Thevathasan T, Skurk C,
Clemmensen P, Hennersdorf M, Fichtlscherer S, Voigt I, Seyfarth M, John S, Ewen
S, Linke A, Tigges E, Nordbeck P, Bruch L, Jung C, Franz J, Lauten P, Noc M,
Fuernau G, Feistritzer HJ, Pöss J, Kirchhof E, Ouarrak T, Schneider S, Freund A,
Thiele H. Routine extracorporeal life support in infarct-related cardiogenic
shock: 1-year results of the ECLS-SHOCK trial. Eur Heart J. 2024 Oct
14;45(39):4200-4203. doi: 10.1093/eurheartj/ehae610. PMID: 39219338.

6: Thiele H, Desch S, Freund A, Zeymer U. Why VA-ECMO should not be used
routinely in AMI-Cardiogenic Shock. J Heart Lung Transplant. 2024
May;43(5):695-699. doi: 10.1016/j.healun.2024.01.006. PMID: 38705699.

7: Rottländer D, Hausleiter J, Schmitz T, Bufe A, Seyfarth M, von Bardeleben RS,
Beucher H, Ouarrak T, Schneider S, Boekstegers P; MITRA‐PRO Investigators.
Impact of residual mitral regurgitation after transcatheter edge-to-edge repair
in atrial functional mitral regurgitation: Results from MITRA-PRO registry.
Catheter Cardiovasc Interv. 2024 Nov;104(5):1015-1026. doi: 10.1002/ccd.31242.
Epub 2024 Sep 26. PMID: 39323306.

8: Rottländer D, Hausleiter J, Schmitz T, Bufe A, Seyfarth M, von Bardeleben RS,
Beucher H, Ouarrak T, Schneider S, Boekstegers P; MITRA-PRO investigators.
Intraprocedural 3D-vena contracta area predicts survival after transcatheter
edge-to-edge repair: results from MITRA-PRO registry. Clin Res Cardiol. 2024 Dec
9. doi: 10.1007/s00392-024-02580-6. Epub ahead of print. PMID: 39652118.

9: Stolpe S, Kowall B, Werdan K, Zeymer U, Bestehorn K, Weber MA, Schneider S,
Stang A. Correction: OECD indicator 'AMI 30-day mortality' is neither comparable
between countries nor suitable as indicator for quality of acute care. Clin Res
Cardiol. 2024 Apr;113(4):651. doi: 10.1007/s00392-023-02342-w. Erratum for: Clin
Res Cardiol. 2024 Dec;113(12):1650-1660. doi: 10.1007/s00392-023-02296-z. PMID:
37991503; PMCID: PMC10954853.

10: Brockmüller C, Meid AD, Senges J, Hochadel M, Haefeli WE, Stoll F.
Phenotypes of Patients with Direct Oral Anticoagulant (DOAC) Underdosing in
Atrial Fibrillation: Results from the ARENA Registry. Clin Drug Investig. 2024
Dec 12. doi: 10.1007/s40261-024-01411-w. Epub ahead of print. PMID: 39666256.

11: Vondran M, Ghazy T, Choi YH, Ouarrak T, Niemann B, Caliskan E, Doll N,
Senges J, Hanke T, Rastan AJ, Case-Af Investigators. Impact of Preoperative
Sinus Rhythm on Concomitant Surgical Ablation's One-Year Success in Patients
with Atrial Fibrillation: A Prospective Registry Cohort Study. J Clin Med. 2024
Sep 29;13(19):5824. doi: 10.3390/jcm13195824. PMID: 39407884; PMCID:
PMC11477891.

12: Imhof S, Hochadel M, Konstantinides S, Voigtländer T, Schmitt C, Nowak B,
Rassaf T, Senges J, Münzel T, Giannitsis E, Breuckmann F. Cardiac, possible
cardiac, and likely non-cardiac origin of chest pain : A hitherto underestimated
parameter in German chest pain units. Herz. 2024 Jun;49(3):175-180. English.
doi: 10.1007/s00059-023-05230-1. Epub 2023 Dec 28. PMID: 38155226.

13: Zeymer U, Riemer T, Wolf U, Schaefer S, Taggeselle J, Kabitz HJ, Prondzinsky
R, Süselbeck T, Kleemann T, Zahn R, Heer T; APAF-Investigators. Impact of Renal
Function Estimation Formulae on Use and Correct Dosing of NOACs in Patients with
Non-valvular Atrial Fibrillation in Real Life in Germany. Am J Cardiovasc Drugs.
2024 Nov 26. doi: 10.1007/s40256-024-00700-1. Epub ahead of print. PMID:
39589707.

14: Fastner C, Müller C, Brachmann J, Lewalter T, Akin I, Sievert H, Käunicke M,
Zeymer U, Hochadel M, Schneider S, Senges J, Erkapic D, Weiß C. Is spontaneous
echo contrast associated with device-related thrombus or embolic events after
left atrial appendage occlusion? - Insights from the multicenter German LAARGE
registry. J Interv Card Electrophysiol. 2024 Jan;67(1):119-128. doi:
10.1007/s10840-023-01567-z. Epub 2023 Jun 1. PMID: 37261553; PMCID: PMC10770218.

15: Alken FA, Senges J, Schneider S, Hochadel M, Brachmann J, Kleemann T,
Eckardt L, Steinbeck G, Leschke M, Stellbrink C, Zrenner B, Becker R, Kahle AK,
Meyer C. Resting heart rate assessed within clinical practice demonstrates no
prognostic relevance for defibrillator recipients in the German DEVICE registry.
Sci Rep. 2024 Nov 25;14(1):29189. doi: 10.1038/s41598-024-78851-z. PMID:
39587151; PMCID: PMC11589132.

16: Engstrøm T, Madsen JM, Thiele H, Zeymer U. Percutaneous transvalvular
microaxial flow pump is underused in infarct-related cardiogenic shock: pros and
cons. EuroIntervention. 2024 Sep 2;20(17):e1059-e1061. doi:
10.4244/EIJ-E-24-00033. PMID: 39219358; PMCID: PMC11352518.

17: Heer T, Zeymer U, Schwarzbach CJ, Seidl K, Rauch-Kröhnert U, Marler S,
Teutsch C, Diener HC, Senges J, Lip GYH, Huisman MV; GLORIA‐AF Investigators.
Characteristics of Patients With Asymptomatic Atrial Fibrillation and Ischemic
Stroke-Insights From the GLORIA-AF Registry (Phase 2). Pacing Clin
Electrophysiol. 2024 Nov 27. doi: 10.1111/pace.15113. Epub ahead of print. PMID:
39603823.

18: Frommeyer G, Reinke F, Brachmann J, Lewalter T, Tilz RR, Willems S, Straube
F, Akin I, Lugenbiel P, Hochadel M, Senges J, Eckardt L. Mortality and
rehospitalization in patients with pre-existing implantable pacemakers
undergoing catheter ablation are related to increased comorbidity burden-data
from the German Ablation Registry. Clin Res Cardiol. 2024 Apr 15. doi:
10.1007/s00392-024-02449-8. Epub ahead of print. PMID: 38619577.

19: Stolpe S, Kowall B, Werdan K, Zeymer U, Bestehorn K, Weber MA, Schneider S,
Stang A. OECD indicator 'AMI 30-day mortality' is neither comparable between
countries nor suitable as indicator for quality of acute care. Clin Res Cardiol.
2024 Dec;113(12):1650-1660. doi: 10.1007/s00392-023-02296-z. Epub 2023 Sep 8.
Erratum in: Clin Res Cardiol. 2024 Apr;113(4):651. doi:
10.1007/s00392-023-02342-w. PMID: 37682307; PMCID: PMC11579078.

20: Heer T, Zeymer U, Hochadel M, Frankenstein L, Pauschinger M, Hambrecht R,
Bruder O, Böhm M, Maier LS, Zahn R, Senges J. Influence of prior myocardial
infarction on outcome in patients with ischaemic HFrEF: insights from the
EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol.
2024 May 8. doi: 10.1007/s00392-024-02455-w. Epub ahead of print. PMID:
38717480.

21: Chung DU, Hochadel M, Senges J, Kleemann T, Eckardt L, Brachmann J,
Steinbeck G, Larbig R, Butter C, Uher T, Willems S, Hakmi S. Procedural Outcome
and 1-Year Follow-Up of Young Patients Undergoing Implantable Cardioverter-
Defibrillator Implantation-Insights from the German DEVICE I+II Registry. J Clin
Med. 2024 Jun 30;13(13):3858. doi: 10.3390/jcm13133858. PMID: 38999424; PMCID:
PMC11242717.

22: Feickert S, Ewertsen NC, Köbe J, Kleemann T, Jehle J, Senges J, Hochadel M,
Andresen D, Stellbrink C, Eckardt L, Spitzer S, Brachmann J, Ince H, D'Ancona G.
Impact of atrial fibrillation on 1-year outcome in patients with implantable
cardioverter defibrillator or cardiac resynchronization therapy with
defibrillator: results from the German DEVICE Registry. J Thorac Dis. 2024 Mar
29;16(3):1825-1835. doi: 10.21037/jtd-23-274. Epub 2024 Mar 27. PMID: 38617758;
PMCID: PMC11009579.

23: Vroomen M, Franke U, Senges J, Friedrich I, Fischlein T, Lewalter T, Ouarrak
T, Niemann B, Liebold A, Hanke T, Doll N, Albert M. Outcomes of surgical
ablation for atrial fibrillation in on- versus off-pump coronary artery bypass
grafting. Interdiscip Cardiovasc Thorac Surg. 2024 Sep 4;39(3):ivae139. doi:
10.1093/icvts/ivae139. PMID: 39120119; PMCID: PMC11401745.

24: Kjesbu IE, Sibilitz KL, Petersen J, Houben VJG, Wilhelm M, Pena-Gil C, Iliou
MC, Zeymer U, Ardissino D, Van't Hof AWJ, van der Velde AE, de Kluiver EP,
Prescott E. Health-related quality of life in elderly cardiac patients
undergoing cardiac rehabilitation and the association with exercise capacity:
the EU-CaRE study. Eur J Prev Cardiol. 2024 Nov 18;31(16):1950-1957. doi:
10.1093/eurjpc/zwae195. PMID: 38838210.

25: Alonso A, Akin I, Hochadel M, Borggrefe M, Lesch H, Grau A, Zahn R,
Lugenbiel P, Schwarzbach CJ, Sueselbeck T, Senges J, Fastner C. Atrial
Fibrillation in Patients with Very High Risk for Stroke and Adverse Events-
Insights from the Observational ARENA Study. J Clin Med. 2024 Nov 6;13(22):6645.
doi: 10.3390/jcm13226645. PMID: 39597789; PMCID: PMC11595193.

26: Zeymer U, Goss F, Kunadt M, Oldenburg S, Hochadel M, Thiele H, Werdan K;
GULLIVE-R Investigators. Patient knowledge about risk factors, achievement of
target values, and guideline-adherent secondary prevention therapies 12 months
after acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2024 Jul
24;13(7):537-545. doi: 10.1093/ehjacc/zuae066. PMID: 38768234.

27: Ansari U, Brachmann J, Lewalter T, Zeymer U, Sievert H, Ledwoch J, Geist V,
Hochadel M, Schneider S, Senges J, Akin I, Fastner C. LAA occlusion is effective
and safe in very high-risk atrial fibrillation patients with prior stroke:
results from the multicentre German LAARGE registry. Clin Res Cardiol. 2024
Oct;113(10):1451-1462. doi: 10.1007/s00392-024-02376-8. Epub 2024 Jan 31. PMID:
38294498; PMCID: PMC11420338.

28: Mitrovic I, Eszlari E, Cvorak A, Liebold A, Rastan A, Grubitzsch H, Knaut M,
Fischlein T, Ouarrak T, Senges J, Hanke T, Doll N, Eichinger W. Epicardial and
endocardial surgical ablation of atrial fibrillation: outcomes from CASE-AF
Registry. Interdiscip Cardiovasc Thorac Surg. 2024 Jul 3;39(1):ivae123. doi:
10.1093/icvts/ivae123. PMID: 38937269; PMCID: PMC11246162.

29: Jung C, Wernly B, Kelm M, Zeymer U, Thiele H; ECLS shock study group.
Quantifying benefit and harm of extracorporeal life support in cardiogenic shock
complicating acute myocardial infarction. Intensive Care Med. 2024
Nov;50(11):1931-1933. doi: 10.1007/s00134-024-07607-0. Epub 2024 Aug 28. PMID:
39196337; PMCID: PMC11541401.

30: Zylla MM, Özdemir B, Hochadel M, Zeymer U, Akin I, Grau A, Schneider S,
Alonso A, Waldecker B, Süselbeck T, Schwacke H, Haass M, Zahn R, Borggrefe M,
Senges J, Frey N, Thomas D. Community-based analysis of stroke prevention and
effect of public interventions in atrial fibrillation: results from the ARENA
project. Clin Res Cardiol. 2024 Aug 8. doi: 10.1007/s00392-024-02510-6. Epub
ahead of print. PMID: 39115608.

31: Thiele H, Desch S, Freund A, Zeymer U. Why VA-ECMO should not be used
routinely in AMI-cardiogenic shock. J Heart Lung Transplant. 2024
Nov;43(11):1912-1913. doi: 10.1016/j.healun.2024.07.013. Epub 2024 Jul 21. PMID:
39043322.

32: Zeymer U, Freund A, Hochadel M, Schneider S, Thiele H. VA-ECMO for infarct-
related cardiogenic shock - Authors' reply. Lancet. 2024 Jun
8;403(10443):2487-2488. doi: 10.1016/S0140-6736(24)00964-4. PMID: 38851286.

33: Borlich M, Zeymer U, Wienbergen H, Hobbach HP, Cuneo A, Bekeredjian R,
Ritter O, Hailer B, Hertting K, Hennersdorf M, Scholtz W, Lanzer P, Mudra H,
Schwefer M, Schwimmbeck PL, Liebetrau C, Thiele H, Claas C, Riemer T, Zahn R,
Iden L, Richardt G, Toelg R. Impact of Access Site on Periprocedural Bleeding
and Cerebral and Coronary Events in High-Bleeding-Risk Percutaneous Coronary
Intervention: Findings from the RIVA-PCI Trial. Cardiol Ther. 2024
Mar;13(1):89-101. doi: 10.1007/s40119-023-00343-4. Epub 2023 Dec 6. PMID:
38055177; PMCID: PMC10899132.

34: Niemann B, Doll N, Grubitzsch H, Hanke T, Knaut M, Senges J, Ouarrak T,
Vondran M, Böning A. Surgical Ablation of Atrial Fibrillation in High-Risk
Patients: Success versus Risk. Thorac Cardiovasc Surg. 2024 Jun 27. doi:
10.1055/a-2334-9039. Epub ahead of print. PMID: 38806162.

35: Thiele H, Desch S, Zeymer U. Microaxial Flow Pump in Infarct-Related
Cardiogenic Shock. N Engl J Med. 2024 Jun 27;390(24):2325-2326. doi:
10.1056/NEJMc2406255. PMID: 38924738.

36: Pöss J, Sinning C, Roßberg M, Hösler N, Ouarrak T, Böttiger BW, Ewen S,
Wienbergen H, Voss F, Dutzmann J, Tigges E, Voigt I, Freund A, Desch S, Michels
G, Thiele H, Zeymer U; G-CAR Investigators. German Cardiac Arrest Registry
(G-CAR)-results of the pilot phase. Clin Res Cardiol. 2024 Jun 13. doi:
10.1007/s00392-024-02468-5. Epub ahead of print. PMID: 38869632.

37: Zeymer U, Freund A, Hochadel M, Ostadal P, Belohlavek J, Massberg S, Brunner
S, Flather M, Adlam D, Hassager C, Moeller JE, Schneider S, Desch S, Thiele H.
Do DanGer-SHOCK-like patients benefit from VA-ECMO treatment in infarct-related
cardiogenic shock? results of an individual patient data meta-analysis. Eur
Heart J Acute Cardiovasc Care. 2024 Sep 25;13(9):658-661. doi:
10.1093/ehjacc/zuae093. PMID: 39217624.

38: Zeymer U, Heer T, Ouarrak T, Akin I, Noc M, Stepinska J, Oldroyd K, Serpytis
P, Montalescot G, Huber K, Windecker S, Savonitto S, Vrints C, Schneider S,
Desch S, Thiele H. Current spectrum and outcomes of infarct-related cardiogenic
shock: insights from the CULPRIT-SHOCK registry and randomized controlled trial.
Eur Heart J Acute Cardiovasc Care. 2024 May 7;13(4):335-346. doi:
10.1093/ehjacc/zuae020. PMID: 38349233.

39: Jung C, Wernly B, Masyuk M, Kelm M, Freund A, Pöss J, Desch S, Schneider S,
Akin I, Schlesinger S, Schrage B, Zeymer U, Thiele H. A Bayesian reanalysis of
the CULPRIT-SHOCK trial. Eur Heart J Acute Cardiovasc Care. 2024 Oct
28;13(10):701-708. doi: 10.1093/ehjacc/zuae104. PMID: 39268887.

40: Sadlonova M, Salzmann S, Senges J, Celano CM, Huffman JC, Borggrefe M, Akin
I, Thomas D, Schwarzbach CJ, Kleemann T, Schneider S, Hochadel M, Süselbeck T,
Schwacke H, Alonso A, Haass M, Ladwig KH, Herrmann-Lingen C. Generalized anxiety
is a predictor of impaired quality of life in patients with atrial fibrillation:
Findings from the prospective observational ARENA study. J Psychosom Res. 2024
Jan;176:111542. doi: 10.1016/j.jpsychores.2023.111542. Epub 2023 Nov 8. PMID:
37977094.

41: Schupp T, Thiele H, Rassaf T, Abbas Mahabadi A, Lehmann R, Eitel I, Skurk C,
Clemmensen P, Hennersdorf M, Voigt I, Linke A, Tigges E, Nordbeck P, Jung C,
Lauten P, Feistritzer HJ, Pöss J, Ouarrak T, Schneider S, Behnes M, Duerschmied
D, Desch S, Freund A, Zeymer U, Akin I. Prognostic Impact of Admission Time in
Infarct-Related Cardiogenic Shock: An ECLS-SHOCK Substudy. JACC Cardiovasc
Interv. 2024 Oct 14;17(19):2228-2239. doi: 10.1016/j.jcin.2024.08.013. PMID:
39415381.

42: Lewalter T, Blomström-Lundqvist C, Lakkireddy D, Packer D, Meyer R, Kuniss M,
Ladwig KH, Jilek C, Diener HC, Boriani G, Turakhia MP, Schneider S, Svennberg E,
Albers B, Andrade JG, de Melis M, Brachmann J. Expert opinion on design and
endpoints for studies on catheter ablation of atrial fibrillation. J Cardiovasc
Electrophysiol. 2024 Nov;35(11):2182-2201. doi: 10.1111/jce.16443. Epub 2024 Sep
25. PMID: 39319521.

43: Stähli BE, Linke A, Westermann D, Van Mieghem NM, Leistner DM, Massberg S,
Alber H, Mügge A, Musumeci G, Kesterke R, Schneider S, Kastrati A, Ford I,
Ruschitzka F, Kasel MA; TAVI PCI Investigators. A randomized comparison of the
treatment sequence of percutaneous coronary intervention and transcatheter
aortic valve implantation: Rationale and design of the TAVI PCI trial. Am Heart
J. 2024 Nov;277:104-113. doi: 10.1016/j.ahj.2024.07.019. Epub 2024 Aug 8. PMID:
39121916.